COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,758 Articles (22,502 medRxiv, 8,256 bioRxiv)

Most recent first Previous |  Page 2702: Articles 27011-27020  | Next

Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate
Arora, K., Rastogi, R., Arora, N. M., Parashar, D., Paliwal, J., Naqvi, A., Srivastava, A., Singh, S. K., Kalyanaraman, S., Potdar, S., Kumar, D., Arya, V. B., Bansal, S., Rautray, S., Singh, I., Fengade, P. S., Kumar, B., Kundu, P. K.
10.1101/2020.05.18.099234 — Posted: 2020-05-19
Antiviral activity of Glucosylceramide synthase inhibitors against SARS-CoV-2 and other RNA virus infections
Vitner, E. B., Avraham, R., Achdout, H., Tamir, H., Agami, A., Cherry, L., Yahalom-Ronen, Y., Politi, B., Erez, N., Melamed, S., Paran, N., Israely, T.
10.1101/2020.05.18.103283 — Posted: 2020-05-19
The impact of super-spreaders in COVID-19: mapping genome variation worldwide
Gomez-Carballa, A., Bello, X., Pardo-Seco, J., Martinon-Torres, F., Salas, A.
10.1101/2020.05.19.097410 — Posted: 2020-05-19
Emerging phylogenetic structure of the SARS-CoV-2 pandemic
Fountain-Jones, N. M., Carol Appaw, R., Carver, S., Didelot, X., Volz, E. M., Charleston, M.
10.1101/2020.05.19.103846 — Posted: 2020-05-19
High Throughput Designing and Mutational Mapping of RBD-ACE2 Interface Guide Non-Conventional Therapeutic Strategies for COVID-19
Padhi, A. K., Kalita, P., Zhang, K. Y. J., Tripathi, T.
10.1101/2020.05.19.104042 — Posted: 2020-05-19
Transcriptional profiling of immune and inflammatory responses in the context of SARS-CoV-2 fungal superinfection in a human airway epithelial model
Nicolas de Lamballerie, C., Pizzorno, A., Fouret, J., szpiro, L., Padey, B., Dubois, J., Julien, T., Traversier, A., Duliere, V., Brun, P., Lina, B., Rosa-Calatrava, M., Terrier, O.
10.1101/2020.05.19.103630 — Posted: 2020-05-19 Discussion: Onsite | Offsite
log(x+1)* and log(1+x)
Booeshaghi, A. S., Pachter, L.
10.1101/2020.05.19.100214 — Posted: 2020-05-19
Isolation of and Characterization of Neutralizing Antibodies to Covid-19 from a Large Human Naïve scFv Phage Display Library
Yuan, A. Q.
10.1101/2020.05.19.104281 — Posted: 2020-05-19
The impact of COVID-19 on African American communities in the United States
Cyrus, E., Clarke, R., Hadley, D., Bursac, Z., Trepka, M. J., Devieux, J. G., Bagci, U., Furr-Holden, D., Coudray, M. S., Mariano, Y., Kiplagat, S., Noel, I., Ravelo, G., Paley, M., Wagner, E. F.
10.1101/2020.05.15.20096552 — Posted: 2020-05-19
Assessment of service availability and Infection prevention measures in hospitals of Nepal during the transition phase of COVID-19 case surge
Bhattarai, S., Dhungana, J., Ensor, T., Shrestha, U. B.
10.1101/2020.05.13.20097675 — Posted: 2020-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).